Jean-Jacques Bienaim

2020

In 2020, Jean-Jacques Bienaim earned a total compensation of $18.1M as Chief Executive Officer at BioMarin Pharmaceutical, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,663,200
Option Awards$3,410,347
Salary$1,298,846
Stock Awards$11,650,975
Other$95,765
Total$18,119,133

Bienaim received $11.7M in stock awards, accounting for 64% of the total pay in 2020.

Bienaim also received $1.7M in non-equity incentive plan, $3.4M in option awards, $1.3M in salary and $95.8K in other compensation.

Rankings

In 2020, Jean-Jacques Bienaim's compensation ranked 270th out of 13,090 executives tracked by ExecPay. In other words, Bienaim earned more than 97.9% of executives.

ClassificationRankingPercentile
All
270
out of 13,090
98th
Division
Manufacturing
86
out of 5,621
99th
Major group
Chemicals And Allied Products
26
out of 2,254
99th
Industry group
Drugs
23
out of 1,954
99th
Industry
Pharmaceutical Preparations
14
out of 1,459
99th

Pay ratio

Jean-Jacques Bienaim's Pay$18,119,133
Median Employee's Pay$181,141
Pay Ratio

100

to 1

In 2020, the annual total compensation of Jean-Jacques Bienaim was $18,119,133.

The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.

The ratio of Jean-Jacques Bienaim's pay to the pay of median employee was therefore 100 to one.

Source: SEC filing on April 13, 2021.

Bienaim's colleagues

We found six more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2020.

2020

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2020

C Guyer

BioMarin Pharmaceutical

Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations

2020

Brian Mueller

BioMarin Pharmaceutical

Chief Financial Officer

2020

Robert Baffi

BioMarin Pharmaceutical

Former President of Global Manufacturing and Technical Operations

2020

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

2020

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

News

You may also like